Outcomes of Purpura FULminans in Adults - The hOPeFUL Study

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

July 27, 2017

Primary Completion Date

March 8, 2018

Study Completion Date

March 8, 2018

Conditions
Purpura Fulminans
Interventions
OTHER

Phone interview measuring health-related quality of life variables

A phone interview will be conducted by a dedicated nurse who will be blinded to the exposed/non-exposed status of the patient.

Trial Locations (26)

6003

Nice University Hospital, Nice

14118

Caen University Hospital, Caen

28000

Chartres Hospital, Chartres

35000

Rennes University Hospital, Rennes

37000

Tours University Hospital, Tours

38100

Grenoble University Hospital, Grenoble

45000

Orléans Hospital, Orléans

51100

Reims University Hospital, Reims

59000

Lilles University Hospital, Lilles

59100

Roubaix Hospital, Roubaix

69003

Edouard Herriot Hospital, Lyon

75010

Saint Louis Hospital, Paris

75012

Saint-Antoine Hospital, Paris

75013

Pitié-Salpétrière Hospital, Paris

75014

Cochin Hospital, Paris

75018

Bichat University Hospital, Paris

76600

Le Havre Hospital, Le Havre

77000

Melun Hospital, Melun

78150

Versailles Hospital, Le Chesnay

78300

Poissy Hospital, Poissy

85925

La Roche sur Yon Hospital, La Roche-sur-Yon

86000

Aulnay sous Bois Hospital, Aulnay-sous-Bois

Poitiers University Hospital, Poitiers

91480

Clinique Gallien, Quincy-sous-Sénart

92700

Louis Mourier Hospital, Colombes

94010

Henri Mondor Hospital, Créteil

All Listed Sponsors
collaborator

Fondation de France

OTHER

lead

Henri Mondor University Hospital

OTHER

NCT03216577 - Outcomes of Purpura FULminans in Adults - The hOPeFUL Study | Biotech Hunter | Biotech Hunter